Morphosys stock news
WebMar 14, 2024 · MorphoSys AG Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update. read more. 03/14/2024. WebMar 23, 2024 · MorphoSys AG invites all eligible holders to offer to sell for cash their convertible bonds due 2025 (ISIN DE000A3H2XW6) Read more. View all news.
Morphosys stock news
Did you know?
WebFeb 10, 2024 · The latest price target for MorphoSys ( NASDAQ: MOR) was reported by JP Morgan on Tuesday, January 3, 2024. The analyst firm set a price target for 0.00 … WebMar 31, 2024 · MorphoSys Stock Performance. The company has a market capitalization of $564.15 million, a P/E ratio of -2.80 and a beta of 1.08. The company has a debt-to-equity ratio of 1.85, a current ratio of ...
WebApr 12, 2024 · A high-level overview of MorphoSys AG (MOR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebStock analysis for MorphoSys AG (MOR:Xetra) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebApr 12, 2024 · See the latest MorphoSys AG ADR stock price (NASDAQ:MOR), related news, valuation, dividends and more to help you make your investing decisions. WebApr 11, 2024 · View MorphoSys AG Unsponsored ADR MOR investment & stock information. Get the latest MorphoSys AG Unsponsored ADR MOR detailed stock …
WebMar 16, 2024 · The stock gained 3.5 percent in after-hours trading compared to the Xetra close. Last year, group sales rose by 55 percent to EUR 278.3 million compared to the …
WebThe MOR stock price is closed at $ 4.00 with a total market cap valuation of $ 546.57M (44M shares outstanding). The MOR is trading on NASDAQ with the sign MOR. MOR … podcast agile team coachingWebApr 7, 2024 · Latest Morphosys Ag (ADR) Stock News. As of April 06, 2024, Morphosys Ag (ADR) had a $622.0 million market capitalization, putting it in the 59th percentile of … podcast after hours transcriptWeb1 day ago · Net-net, we upgrade MorphoSys to a buy rating based on the favorable risk/reward dynamic considering a) close to negative EV (currently ~$30M) valuation, b) clear pelabresib catalyst in YE 2024 ... podcast agile elearningWebReal time MorphoSys Ag (MOR) stock price quote, stock graph, news & analysis. podcast ahora sportingWebGet the latest MorphoSys AG (MOR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … podcast agatha christieWebWhy Shares of MorphoSys Are Up Wednesday. Shares of MorphoSys (NASDAQ: MOR) were up more than 16% Wednesday afternoon after the biopharmaceutical company … podcast alfred lagardeWeb1 day ago · Company. MorphoSys AG is a global commercial-stage biopharmaceutical company based in Germany. The Company discovers, develops, and delivers cancer … podcast aggregators and directories